UnitedHealth Sells Partial WellMed Stake to TPG

UnitedHealth confirmed in a statement this week that it sold a partial stake in its Optum Health Florida primary-care clinic network, including WellMed operations, to private equity firm TPG. The company’s shares moved slightly lower following the announcement.

Under the agreement, UnitedHealth will retain an ongoing equity interest in the Florida clinic footprint while TPG joins as a financial and operational partner. Company documents say the joint venture will support expansion of the clinic network in Florida and target roughly 15 new locations a year.

The transaction brings outside growth capital into Optum Health’s regional clinic business and shifts some capital and operating responsibilities to the joint venture. UnitedHealth described the arrangement as a repeatable, asset-light approach that uses third-party co-investment to expand the clinic footprint rather than funding all growth from the balance sheet.

The sale will generate cash proceeds that management may use to pay down debt, fund share buybacks or reallocate capital to higher-margin businesses such as OptumRx pharmacy services and Optum Insight technology operations. UnitedHealth has reported pressure on margins in its care-delivery units amid elevated medical costs affecting value-based care results; the partial sale reduces direct capital exposure tied to the Florida clinics.

TPG will assume some operational and clinical responsibilities within the joint venture, while UnitedHealth retains strategic control and participation in future earnings from the remaining stake. Company materials say the partnership is intended to help scale operations without Optum bearing the full capital expense of expansion.

On the market, UnitedHealth shares dipped after the disclosure. The stock is roughly 50% higher than a late-March low this year. Analysts, on average, rate UnitedHealth shares as Overweight, with a mean price target near $480.

UnitedHealth positioned the deal as part of broader efforts to stabilize underwriting performance in its insurance business and to scale technology-driven care delivery platforms. The company stated the transaction allows it to monetize part of a mature asset base while sharing operational costs with a private equity partner.